Retargeting gene delivery using surface-engineered retroviral vector particles

Dimitri Lavillette, Stephen J Russell, F. L. Cosset

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Retroviral vectors with the capacity to deliver transgenes to specific tissues are expected to be of great value for various gene transfer applications in vivo. Initial attempts to modify vector host-range by the insertion of ligands on their surface glycoproteins have frequently failed, essentially owing to the impairment of the fusogenicity of the vector particles bound to the targeted cell-surface molecules. Several strategies aimed to recover the fusogenic activity of surface-engineered vector particles have recently been explored and have given rise to novel concepts in the field.

Original languageEnglish (US)
Pages (from-to)461-466
Number of pages6
JournalCurrent Opinion in Biotechnology
Volume12
Issue number5
DOIs
StatePublished - Oct 1 2001

Fingerprint

Host Specificity
Membrane Glycoproteins
Transgenes
Genes
Ligands
Gene transfer
Glycoproteins
Tissue
Molecules

ASJC Scopus subject areas

  • Biotechnology

Cite this

Retargeting gene delivery using surface-engineered retroviral vector particles. / Lavillette, Dimitri; Russell, Stephen J; Cosset, F. L.

In: Current Opinion in Biotechnology, Vol. 12, No. 5, 01.10.2001, p. 461-466.

Research output: Contribution to journalArticle

@article{875487a89aef4ad0b7499b34ad99429f,
title = "Retargeting gene delivery using surface-engineered retroviral vector particles",
abstract = "Retroviral vectors with the capacity to deliver transgenes to specific tissues are expected to be of great value for various gene transfer applications in vivo. Initial attempts to modify vector host-range by the insertion of ligands on their surface glycoproteins have frequently failed, essentially owing to the impairment of the fusogenicity of the vector particles bound to the targeted cell-surface molecules. Several strategies aimed to recover the fusogenic activity of surface-engineered vector particles have recently been explored and have given rise to novel concepts in the field.",
author = "Dimitri Lavillette and Russell, {Stephen J} and Cosset, {F. L.}",
year = "2001",
month = "10",
day = "1",
doi = "10.1016/S0958-1669(00)00246-9",
language = "English (US)",
volume = "12",
pages = "461--466",
journal = "Current Opinion in Biotechnology",
issn = "0958-1669",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Retargeting gene delivery using surface-engineered retroviral vector particles

AU - Lavillette, Dimitri

AU - Russell, Stephen J

AU - Cosset, F. L.

PY - 2001/10/1

Y1 - 2001/10/1

N2 - Retroviral vectors with the capacity to deliver transgenes to specific tissues are expected to be of great value for various gene transfer applications in vivo. Initial attempts to modify vector host-range by the insertion of ligands on their surface glycoproteins have frequently failed, essentially owing to the impairment of the fusogenicity of the vector particles bound to the targeted cell-surface molecules. Several strategies aimed to recover the fusogenic activity of surface-engineered vector particles have recently been explored and have given rise to novel concepts in the field.

AB - Retroviral vectors with the capacity to deliver transgenes to specific tissues are expected to be of great value for various gene transfer applications in vivo. Initial attempts to modify vector host-range by the insertion of ligands on their surface glycoproteins have frequently failed, essentially owing to the impairment of the fusogenicity of the vector particles bound to the targeted cell-surface molecules. Several strategies aimed to recover the fusogenic activity of surface-engineered vector particles have recently been explored and have given rise to novel concepts in the field.

UR - http://www.scopus.com/inward/record.url?scp=0035477273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035477273&partnerID=8YFLogxK

U2 - 10.1016/S0958-1669(00)00246-9

DO - 10.1016/S0958-1669(00)00246-9

M3 - Article

C2 - 11604321

AN - SCOPUS:0035477273

VL - 12

SP - 461

EP - 466

JO - Current Opinion in Biotechnology

JF - Current Opinion in Biotechnology

SN - 0958-1669

IS - 5

ER -